Anúncio
Anúncio
PRME
Prime Medicine, Inc. Common Stock
3.93
USDPatrocinado
+0.01
+0.23%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
3.97
+0.04
+1.04%
Relatórios de Lucros PRME
Rácio de surpresa positiva
PRME separação 3 de 12 últimas estimativas.
25%
Próximo Relatório
Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.35M
/-$0.25
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+92.11%
/-21.88%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+7.80%
/-19.35%
Prime Medicine, Inc. Common Stock earnings per share and revenue
On 07 de nov. de 2025, PRME reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.25 USD, resulting in a -23.98% surprise. Revenue reached 1.23 milhão, compared to an expected 1.05 milhão, with a 17.04% difference. The market reacted with a -8.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analistas forecast an EPS of -0.25 USD, with revenue projected to reach 2.35 milhão USD, implying an diminuir of -21.88% EPS, and aumentar of 92.11% in Revenue from the last quarter.
FAQ
What were Prime Medicine, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Prime Medicine, Inc. Common Stock reported EPS of -$0.32, missing estimates by -23.98%, and revenue of $1.23M, 17.04% above expectations.
How did the market react to Prime Medicine, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -8.85%, changed from $4.18 before the earnings release to $3.81 the day after.
When is Prime Medicine, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26 de fev. de 2026.
What are the forecasts for Prime Medicine, Inc. Common Stock's next earnings report?
Based on 14
analistas, Prime Medicine, Inc. Common Stock is expected to report EPS of -$0.25 and revenue of $2.35M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio